Fragment-Based Interrogation of the 14-3-3/TAZ Protein-Protein Interaction.

Blaž Andlovic, Dario Valenti, Federica Centorrino, Francesca Picarazzi, Stanimira Hristeva, Malgorzata Hiltmann, Alexander Wolf, François-Xavier Cantrelle, Mattia Mori, Isabelle Landrieu, Laura M Levy, Bert Klebl, Dimitrios Tzalis, Thorsten Genski, Jan Eickhoff, Christian Ottmann
Author Information
  1. Blaž Andlovic: Lead Discovery Center GmbH, Otto-Hahn-Str. 15, 44227 Dortmund, Germany.
  2. Dario Valenti: Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands.
  3. Federica Centorrino: Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands.
  4. Francesca Picarazzi: Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
  5. Stanimira Hristeva: Taros Chemicals GmbH & Co. KG, Emil-Figge-Straße 76a, 44227 Dortmund, Germany.
  6. Malgorzata Hiltmann: Lead Discovery Center GmbH, Otto-Hahn-Str. 15, 44227 Dortmund, Germany.
  7. Alexander Wolf: Lead Discovery Center GmbH, Otto-Hahn-Str. 15, 44227 Dortmund, Germany.
  8. François-Xavier Cantrelle: CNRS EMR9002 Integrative Structural Biology, University of Lille, F-59000 Lille, France. ORCID
  9. Mattia Mori: Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy. ORCID
  10. Isabelle Landrieu: CNRS EMR9002 Integrative Structural Biology, University of Lille, F-59000 Lille, France. ORCID
  11. Laura M Levy: Taros Chemicals GmbH & Co. KG, Emil-Figge-Straße 76a, 44227 Dortmund, Germany.
  12. Bert Klebl: Lead Discovery Center GmbH, Otto-Hahn-Str. 15, 44227 Dortmund, Germany.
  13. Dimitrios Tzalis: Taros Chemicals GmbH & Co. KG, Emil-Figge-Straße 76a, 44227 Dortmund, Germany.
  14. Thorsten Genski: Taros Chemicals GmbH & Co. KG, Emil-Figge-Straße 76a, 44227 Dortmund, Germany.
  15. Jan Eickhoff: Lead Discovery Center GmbH, Otto-Hahn-Str. 15, 44227 Dortmund, Germany.
  16. Christian Ottmann: Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands. ORCID

Abstract

The identification of chemical starting points for the development of molecular glues is challenging. Here, we employed fragment screening and identified an allosteric stabilizer of the complex between 14-3-3 and a TAZ-derived peptide. The fragment binds preferentially to the 14-3-3/TAZ peptide complex and shows moderate stabilization in differential scanning fluorimetry and microscale thermophoresis. The binding site of the fragment was predicted by molecular dynamics calculations to be distant from the 14-3-3/TAZ peptide interface, located between helices 8 and 9 of the 14-3-3 protein. This site was confirmed by nuclear magnetic resonance and X-ray protein crystallography, revealing the first example of an allosteric stabilizer for 14-3-3 protein-protein interactions.

References

  1. J Struct Biol. 2018 Jun;202(3):210-215 [PMID: 29408703]
  2. Nat Struct Mol Biol. 2020 Feb;27(2):134-141 [PMID: 31988522]
  3. Clin Sci (Lond). 2022 Feb 11;136(3):197-222 [PMID: 35119068]
  4. J Med Chem. 2018 Sep 27;61(18):8120-8135 [PMID: 30137981]
  5. J Chem Theory Comput. 2013 Jul 9;9(7):3084-95 [PMID: 26583988]
  6. Cell Res. 2015 Mar;25(3):306-17 [PMID: 25675982]
  7. J Biol Chem. 2008 Mar 21;283(12):7411-20 [PMID: 18211894]
  8. FEBS Lett. 2010 Apr 16;584(8):1443-8 [PMID: 20206173]
  9. J Med Chem. 2020 Jul 9;63(13):6694-6707 [PMID: 32501690]
  10. Pharmacol Res. 2021 Jan;163:105236 [PMID: 33053447]
  11. J Comput Chem. 2004 Jul 15;25(9):1157-74 [PMID: 15116359]
  12. Bioinformatics. 2012 Feb 1;28(3):439-40 [PMID: 22135419]
  13. Adv Protein Chem Struct Biol. 2022;130:289-324 [PMID: 35534110]
  14. Cell Res. 2005 Apr;15(4):219-27 [PMID: 15857576]
  15. Nat Med. 2013 Feb;19(2):202-8 [PMID: 23291630]
  16. Int J Mol Sci. 2019 Jul 18;20(14): [PMID: 31323761]
  17. J Mol Model. 2006 Feb;12(3):281-9 [PMID: 16240095]
  18. FEBS Lett. 2002 Feb 20;513(1):53-7 [PMID: 11911880]
  19. Nat Commun. 2018 Sep 17;9(1):3785 [PMID: 30224724]
  20. FEBS Lett. 1994 Sep 26;352(2):163-6 [PMID: 7925968]
  21. Mol Cancer Ther. 2017 Jun;16(6):1010-1020 [PMID: 28341788]
  22. Molecules. 2017 May 18;22(5): [PMID: 28524077]
  23. Eur J Med Chem. 2024 Jan 5;263:115950 [PMID: 37984298]
  24. Sci Transl Med. 2016 Mar 30;8(332):332ra45 [PMID: 27030597]
  25. Nat Commun. 2022 Jun 23;13(1):3586 [PMID: 35739107]
  26. Nucleic Acids Res. 2008 Oct;36(18):5983-91 [PMID: 18812399]
  27. Angew Chem Int Ed Engl. 2012 Feb 27;51(9):2012-8 [PMID: 22308055]
  28. Genes Dev. 1997 May 1;11(9):1132-9 [PMID: 9159394]
  29. ACS Chem Biol. 2020 Dec 18;15(12):3143-3148 [PMID: 33196173]
  30. EMBO J. 2008 Sep 3;27(17):2305-16 [PMID: 19172738]
  31. Angew Chem Int Ed Engl. 2023 Sep 11;62(37):e202308004 [PMID: 37455289]
  32. Biochemistry. 2017 Aug 1;56(30):3972-3982 [PMID: 28681606]
  33. Chem Soc Rev. 2022 Jun 20;51(12):5214-5236 [PMID: 35671157]
  34. Cell. 2001 Apr 20;105(2):257-67 [PMID: 11336675]
  35. Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17237-42 [PMID: 17085597]
  36. ChemMedChem. 2016 Apr 19;11(8):911-8 [PMID: 26644359]
  37. Sci Rep. 2017 Sep 20;7(1):12014 [PMID: 28931924]
  38. Medchemcomm. 2019 Jul 22;10(10):1796-1802 [PMID: 31814953]
  39. NPJ Parkinsons Dis. 2021 Sep 21;7(1):85 [PMID: 34548498]
  40. J Chem Inf Model. 2015 Dec 28;55(12):2611-22 [PMID: 26551337]
  41. Proc Natl Acad Sci U S A. 2013 May 28;110(22):8894-9 [PMID: 23676274]
  42. Nat Commun. 2020 Aug 7;11(1):3954 [PMID: 32770072]
  43. J Biol Chem. 2008 Sep 5;283(36):24899-908 [PMID: 18606808]
  44. Biomol NMR Assign. 2019 Apr;13(1):103-107 [PMID: 30377945]
  45. Biochem Biophys Res Commun. 2023 Apr 9;651:1-7 [PMID: 36774661]
  46. Curr Opin Chem Biol. 2011 Aug;15(4):489-96 [PMID: 21665521]
  47. Angew Chem Int Ed Engl. 2020 Nov 23;59(48):21520-21524 [PMID: 32816380]
  48. PLoS One. 2014 Mar 21;9(3):e92902 [PMID: 24658679]
  49. Nat Rev Drug Discov. 2012 Nov;11(11):873-86 [PMID: 23060265]
  50. Curr Opin Chem Biol. 2022 Aug;69:102169 [PMID: 35749929]
  51. Front Mol Neurosci. 2022 Mar 14;15:857495 [PMID: 35359567]
  52. J Chem Inf Model. 2020 Dec 28;60(12):6555-6565 [PMID: 33138374]
  53. J Med Chem. 2020 Jan 9;63(1):52-65 [PMID: 31820981]
  54. Mol Cell Biol. 2010 Oct;30(19):4698-711 [PMID: 20679480]
  55. FEBS Lett. 2018 Apr;592(7):1211-1220 [PMID: 29473952]
  56. J Med Chem. 2013 Mar 14;56(5):2059-73 [PMID: 23394218]
  57. J Biol Chem. 2019 Aug 30;294(35):13106-13116 [PMID: 31308176]
  58. Trends Cancer. 2019 May;5(5):297-307 [PMID: 31174842]
  59. Cell Chem Biol. 2023 Jun 15;30(6):573-590.e6 [PMID: 37130519]
  60. Biochem J. 2012 Oct 1;447(1):159-66 [PMID: 22827337]
  61. Structure. 2017 Feb 7;25(2):305-316 [PMID: 28089448]
  62. N Engl J Med. 2015 Jul 30;373(5):428-37 [PMID: 26222558]
  63. J Am Chem Soc. 2019 Feb 27;141(8):3524-3531 [PMID: 30707565]
  64. Mol Biol Cell. 2012 Mar;23(6):996-1009 [PMID: 22278744]
  65. Sci Rep. 2022 Jul 8;12(1):11596 [PMID: 35804047]
  66. Protein Sci. 2023 Nov;32(11):e4805 [PMID: 37817008]
  67. J Cell Sci. 2006 Oct 1;119(Pt 19):4059-70 [PMID: 16968750]
  68. Biochemistry. 2003 May 6;42(17):5058-64 [PMID: 12718549]
  69. Cell Chem Biol. 2020 Jun 18;27(6):657-667.e6 [PMID: 32220335]
  70. MedComm (2020). 2023 Oct 03;4(5):e375 [PMID: 37799806]
  71. Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):E1152-61 [PMID: 26888287]
  72. Biochem J. 2017 Mar 23;474(7):1273-1287 [PMID: 28202711]
  73. Sci Signal. 2020 Sep 01;13(647): [PMID: 32873725]
  74. Nat Rev Drug Discov. 2016 Aug;15(8):533-50 [PMID: 27050677]
  75. Int J Mol Sci. 2020 Nov 21;21(22): [PMID: 33233473]
  76. Hum Mol Genet. 2016 Jan 1;25(1):109-22 [PMID: 26546614]
  77. Biochem Soc Trans. 2018 Dec 17;46(6):1393-1406 [PMID: 30381334]

MeSH Term

14-3-3 Proteins
Humans
Protein Binding
Crystallography, X-Ray
Binding Sites
Molecular Dynamics Simulation
Transcription Factors
Acyltransferases

Chemicals

14-3-3 Proteins
Transcription Factors
Acyltransferases
TAFAZZIN protein, human

Word Cloud

Created with Highcharts 10.0.0fragment14-3-3peptide14-3-3/TAZmolecularallostericstabilizercomplexsiteproteinidentificationchemicalstartingpointsdevelopmentglueschallengingemployedscreeningidentifiedTAZ-derivedbindspreferentiallyshowsmoderatestabilizationdifferentialscanningfluorimetrymicroscalethermophoresisbindingpredicteddynamicscalculationsdistantinterfacelocatedhelices89confirmednuclearmagneticresonanceX-raycrystallographyrevealingfirstexampleprotein-proteininteractionsFragment-BasedInterrogationProtein-ProteinInteraction

Similar Articles

Cited By